Quick Answer
IMMUCELL CORP /DE/ reported Long-Term Debt of $7.49 million for fiscal year 2025.
IMMUCELL CORP /DE/ Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $7.49M | -17.2% |
| 2024 | $9.04M | +873.0% |
| 2013 | $929.2K | -20.6% |
| 2012 | $1.17M | -12.4% |
| 2011 | $1.34M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.90M | — | -4.4% |
| June 30, 2025 | $8.26M | — | -8.6% |
| December 31, 2024 | $9.04M | — | +977.9% |
| June 30, 2014 | $838.8K | -19.0% | -5.0% |
| March 31, 2014 | $882.5K | -20.7% | -5.0% |
| December 31, 2013 | $929.2K | -20.6% | -5.9% |
| September 30, 2013 | $987.9K | -19.1% | -4.6% |
| June 30, 2013 | $1.04M | — | -7.0% |
- IMMUCELL CORP /DE/ showed a decrease of -17.2% in Long-Term Debt compared to the prior fiscal year.
- Over the 2011–2025 period, IMMUCELL CORP /DE/’s long-term debt has grown by 460.6% (from $1.34 million to $7.49 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: